NEW YORK (GenomeWeb News) – DiaGenic said today that lab services firm DNAVision will offer the firm’s blood-based gene expression tests for early detection of breast cancer and Alzheimer’s disease.
 
The Oslo-based molecular diagnostics firm said that DNAVision would offer the tests through its CLIA/ISO17025-certified facilities.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An analysis has examined the makeup of researchers on Twitter and what they share, Nature News reports.

At Stat News, Jim Kozubek argues that the Broad Institute is pushing the boundary of what a nonprofit is.

In PNAS this week: gut microbes may affect honeybee weight, phenotype and gene expression changes in DiGeorge syndrome, and more.

Vivek Murthy is no longer the surgeon general of the US, the Associated Press reports.